Specific inhibitors of type 2 cyclooxygenase less renal effects than classical non steroidal anti-inflammatory agents?;Les inhibiteurs sélectifs de la cyclooxygénase de type 2: Moins d'effets rénaux que les anti-inflammatoires non stéroïdiens classiques?

Nephrologie

Volumn 21, Issue 8, 2000, Pages 425-430

  Chiolero, A ^a   Wurzner G ^a   Burnier, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Celecoxib; Cyclo oxygenase 2; Hemodynamics; Prostaglandins; Renal; Rofecoxib; Selective inhibitors; Sodium

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; RENIN; ROFECOXIB; THROMBOXANE A2; THROMBOXANE B2;

ACUTE KIDNEY FAILURE; DRUG SAFETY; ENZYME INHIBITION; HUMAN; KIDNEY BLOOD FLOW; NEPHROTOXICITY; PATHOPHYSIOLOGY; PROSTAGLANDIN METABOLISM; REVIEW; SODIUM EXCRETION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GASTROINTESTINAL DISEASES; HUMANS; ISOENZYMES; KIDNEY; KIDNEY DISEASES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RENIN;

EID: 0034492994     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. A classification of NSAIDS according to the relative inhibition of cyclooxygenase isoenzymes
2. Selective COX-2 inhibitors: Is the water becoming muddy?
3. COX-2 inhibitors
4. Pain management in osteoarthritis: The role of COX-2 inhibitors
5. Arachidonic acid metabolites and the kidney
6. Nonsteroidal anti-inflammatory drugs (NSAIDS) and the kidney
7. Non-steroidal anti-inflammatory drug-induced renal failure: A brief review of the role of cyclooxygenase isoforms
8. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake
9. Regulation of cyclooxygenase expression in the kidney by dietary salt intake
10. Juxtaglomerular cell complex in the regulation of renal salt excretion
11. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
12. Localisation of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
13. Cyclooxygenase-2 expression is associated with the macula-densa in kidneys from patients with Bartter like syndrome
14. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet
15. Nitric oxyde and protaglandins are involved in the macula densa control of the renin system
16. Role of nitric oxide in the control of renin excretion
17. Inhibition of the renin-angiotensin sytem upregulates cyclooxygenase-2 expression in the macula densa
18. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression
19. Cyclooxygenase-2 inhibition decreases renin content and lowers blood presssure in a model of renovascular hypertension
20. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
21. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
22. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
23. Selective increase of cyclooxygenase-2 expression in a model of renal ablation
24. Cycooxygenase-2 (COX-2) inhibition decreases proteinuria in a hypertensive diabetic model
25. Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor
26. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
27. Effects of specific inhibition of cyclooxygeanse-2 on sodium balance, hemodynamics and vasoactive eicosanoids
28. Renal effects of multiple-dose rofecoxib, a Cox-2 inhibitor, in elderly subjects
29. Effects of celecoxib and naproxen on renal function in the elderly
30. Unifying hypothesis of sodium and water regulation in health and disease
31. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
32. A meta-analysis of non-steroidal anti-inflammatory drugs on blood pressure
33. Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: Will such treatments improve renal function outcome?
34. Cyclooxygenase-2 inhibition decreases proteinuria in a hypertensive diabetic model